Skip To Main Content
  • Article
  • Source: Campus Sanofi

Control glucémico: estrategias clínicas

Importancia del control glucémico y estrategias clínicas para optimizar el manejo de la diabetes.

Debes ser un profesional de la salud para continuar leyendo este contenido.

¿Eres un profesional de la salud?

Regístrate para obtener acceso exclusivo a las últimas noticias sobre avances científicos y a recursos que mejoren la vida de tus pacientes.

Obtenga acceso a información para profesionales de la salud y edite los temas relevantes para usted en su perfil.

¿Olvidó su contraseña?
¿Aún no está registrado? Register
The account is under our identity verification process. When complete you will receive a confirmation email and you will be able to access the area dedicated to you.

Por favor revise su correo electrónico para ver el correo electrónico de verificación.

Gracias por registrarse, revise su correo electrónico para completar el registro.

No tienes el rol verificado correcto para ver este contenido.

Registro

¡Email enviado!
Este correo electrónico está disponible.

1 letra mayúscula
1 letra minúscula
1 numero
8 caracteres

Tus contraseñas coinciden.

Áreas de interés

 

Seleccione sus áreas de interés

Tratamiento de datos personales

*
¿Ya tienes una cuenta? |

Revisa tu bandeja de entrada de correo electrónico para activar tu cuenta

¡Email enviado!

Se ha enviado un correo electrónico de verificación al correo electrónico con el que se registró. Para activar su cuenta, haga clic en el enlace de este correo electrónico. Si no ha recibido el correo electrónico de verificación, haga clic en el botón a continuación.

De vuelta a casa

Welcome to Sanofi Campus

g

Referencias

  1. Polonsky WH, Capehorn M, Belton A, et al. Physician-patient communication at diagnosis of Type 2 Diabetes and its links to patient outcomes: new results from the global IntroDia® study. Diabetes Res Clin Pract. 2017;127:265-274. doi:10.1016/j.diabres.2017.03.016
  2. Khunti K, Zaccardi F, Amod A, et al. Glycemic control is still central in the hierarchy of priorities in Type 2 Diabetes management. Diabetologia. 2025;68(1):17-28. doi:10.1007/s00125-024-06254-w
  3. Testa MA, Simonson DC. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial. JAMA. 1998;280(17):1490-1496. doi:10.1001/jama.280.17.1490
  4. Banasiak K, Cleary D, Bajurny V, et al. Language Matters – A Diabetes Canada Consensus Statement. Can J Diabetes. 2020;44(5):370-373. doi:10.1016/j.jcjd.2020.05.008
  5. Yahaya JJ, Doya IF, Morgan ED, Ngaiza AI, Bintabara D. Poor glycemic control and associated factors among patients with Type 2 Diabetes mellitus: a cross-sectional study. Sci Rep. 2023;13(1):9673. Published 2023 Jun 14. doi:10.1038/s41598-023-36675-3
  6. Sun B, Luo Z, Zhou J. Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications. Cardiovasc Diabetol. 2021;20(1):9. Published 2021 Jan 7. doi:10.1186/s12933-020-01200-7
  7. Battelino T, Danne T, Bergenstal RM, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International consensus on time in range. Diabetes Care. 2019;42(8):1593- 1603. doi:10.2337/dci19-0028
  8. Brod M, Alolga SL, Meneghini L. Barriers to initiating insulin in Type 2 Diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities. Patient. 2014;7(4):437-450. doi:10.1007/s40271-014-0068-x
  9. Reach G, Pechtner V, Gentilella R, Corcos A, Ceriello A. Clinical inertia and its impact on treatment intensification in people with Type 2 Diabetes mellitus. Diabetes Metab. 2017;43(6):501-511. doi:10.1016/j.diabet.2017.06.003
  10. Dickinson JK, Guzman SJ, Maryniuk MD, et al. The use of language in diabetes care and education. Diabetes Care. 2017;40(12 ):1790-1799. doi:10.2337/dci17-0041
  11. Essien O, Otu A, Umoh V, Enang O, Hicks JP, Walley J. Intensive patient education improves glycemic control in diabetes compared to conventional education: a randomised controlled trial in a Nigerian tertiary care hospital. PLoS One. 2017;12(1):e0168835. Published 2017 Jan 3. doi:10.1371/journal.pone.0168835
  12. Holmes-Truscott E, Browne JL, Ventura AD, Pouwer F, Speight J. Diabetes stigma is associated with negative treatment appraisals among adults with insulin-treated Type 2 diabetes: results from the second Tiabetes MILES - Australia (MILES-2) survey. Diabet Med. iabet Med. 2018;35(5):658-662. doi:10.1111/dme.13598
  13. Khunti K, Wolden ML, Thorsted BL, Andersen M, Davies MJ. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care. 2013;36(11):3411-3417. doi:10.2337/dc13- 0331
  14. American Diabetes Association. 4. Lifestyle Management. Diabetes Care. 2017;40(Suppl 1):S33-S43. doi:10.2337/dc17-S007
  15. Colberg SR, Sigal RJ, Yardley JE, et al. Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016;39(11):2065-2079. doi:10.2337/dc16-1728
  16. Reutrakul S, Van Cauter E. Sleep influences on obesity, insulin resistance, and risk of type 2 diabetes. Metabolism. 2018;84:56-66. doi:10.1016/j.metabol.2018.02.010
  17. Strom JL, Egede LE. The impact of social support on outcomes in adult patients with type 2 diabetes: a systematic review. Curr Diab Rep. 2012;12(6):769-781. doi:10.1007/s11892-012-0317-0
  18. Polonsky WH, Fisher L, Schikman CH, et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the structured testing program study. Diabetes Care. 2011;34(2):262-267. doi:10.2337/dc10-1732
  19. Beck RW, Riddlesworth T, Ruedy K, et al. Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA. 2017;317(4):371- 378. doi:10.1001/jama.2016.19975
  20. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 Diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837-853.
  21. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577-1589. doi:10.1056/NEJMoa0806470
  22. American Diabetes Association Professional Practice Committee; 6. Glycemic goals and hypoglycemia: standards of care in diabetes—2024. Diabetes Care 1 January 2024; 47 (Supplement_1): S111– S125. https://doi.org/10.2337/dc24-S006
  23. Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord. 2012;142 Suppl:S8-S21. doi:10.1016/S0165- 0327(12)70004-6
MAT-AR-2502733 2027-10-22